|
1
|
Caplan AI: Mesenchymal stem cells. J
Orthop Res. 9:641–650. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Deans RJ and Moseley AB: Mesenchymal stem
cells: biology and potential clinical uses. Exp Hematol.
28:875–884. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pittenger MF, Mackay AM, Beck SC, et al:
Multilineage potential of adult human mesenchymal stem cells.
Science. 284:143–147. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ferrari G, Cusella-De Angelis G, Coletta
M, et al: Muscle regeneration by bone marrow-derived myogenic
progenitors. Science. 279:1528–1530. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liechty KW, MacKenzie TC, Shaaban AF, et
al: Human mesenchymal stem cells engraft and demonstrate
site-specific differentiation after in utero transplantation in
sheep. Nat Med. 6:1282–1286. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pereira RF, O’Hara MD, Laptev AV, et al:
Marrow stromal cells as a source of progenitor cells for
nonhematopoietic tissues in transgenic mice with a phenotype of
osteogenesis imperfecta. Proc Natl Acad Sci USA. 95:1142–1147.
1998.PubMed/NCBI
|
|
7
|
Di Nicola M, Carlo-Stella C, Magni M, et
al: Human bone marrow stromal cells suppress T-lymphocyte
proliferation induced by cellular or nonspecific mitogenic stimuli.
Blood. 99:3838–3843. 2002.
|
|
8
|
Krampera M, Glennie S, Dyson J, et al:
Bone marrow mesenchymal stem cells inhibit the response of naive
and memory antigen-specific T cells to their cognate peptide.
Blood. 101:3722–3729. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Aggarwal S and Pittenger MF: Human
mesenchymal stem cells modulate allogeneic immune cell responses.
Blood. 105:1815–1822. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bartholomew A, Sturgeon C, Siatskas M, et
al: Mesenchymal stem cells suppress lymphocyte proliferation in
vitro and prolong skin graft survival in vivo. Exp Hematol.
30:42–48. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Le Blanc K, Rasmusson I, Sundberg B, et
al: Treatment of severe acute graft-versus-host disease with third
party haploidentical mesenchymal stem cells. Lancet. 363:1439–1441.
2004.PubMed/NCBI
|
|
12
|
Zappia E, Casazza S, Pedemonte E, et al:
Mesenchymal stem cells ameliorate experimental autoimmune
encephalomyelitis inducing T-cell anergy. Blood. 106:1755–1761.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zheng ZH, Li XY, Ding J, Jia JF and Zhu P:
Allogeneic mesenchymal stem cell and mesenchymal stem
cell-differentiated chondrocyte suppress the responses of type II
collagen-reactive T cells in rheumatoid arthritis. Rheumatology
(Oxford). 47:22–30. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen FH and Tuan RS: Mesenchymal stem
cells in arthritic diseases. Arthritis Res Ther. 10:2232008.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Baxter MA, Wynn RF, Jowitt SN, Wraith JE,
Fairbairn LJ and Bellantuono I: Study of telomere length reveals
rapid aging of human marrow stromal cells following in vitro
expansion. Stem Cells. 22:675–682. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bonab MM, Alimoghaddam K, Talebian F,
Ghaffari SH, Ghavamzadeh A and Nikbin B: Aging of mesenchymal stem
cell in vitro. BMC Cell Biol. 71:42006.
|
|
17
|
Weyand CM and Goronzy JJ: Stem cell aging
and autoimmunity in rheumatoid arthritis. Trends Mol Med.
10:426–433. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Morimoto D, Kuroda S, Kizawa T, et al:
Equivalent osteoblastic differentiation function of human
mesenchymal stem cells from rheumatoid arthritis in comparison with
osteoarthritis. Rheumatology (Oxford). 48:643–649. 2009. View Article : Google Scholar
|
|
19
|
Kassem M, Ankersen L, Eriksen EF, Clark BF
and Rattan SI: Demonstration of cellular aging and senescence in
serially passaged long-term cultures of human trabecular
osteoblasts. Osteoporos Int. 7:514–524. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dimri GP, Lee X, Basile G, et al: A
biomarker that identifies senescent human cells in culture and in
aging skin in vivo. Proc Natl Acad Sci USA. 92:9363–9367. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Groh ME, Maitra B, Szekely E and Koc ON:
Human mesenchymal stem cells require monocyte-mediated activation
to suppress alloreactive T cells. Exp Hematol. 33:928–934. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Le Blanc K, Rasmusson I, Gotherstrom C, et
al: Mesenchymal stem cells inhibit the expression of CD25
(interleukin-2 receptor) and CD38 on phytohaemagglutinin-activated
lymphocytes. Scand J Immunol. 60:307–315. 2004.PubMed/NCBI
|
|
23
|
Zhu P, Li XY, Wang HK, et al: Oral
administration of type-II collagen peptide 250–270 suppresses
specific cellular and humoral immune response in collagen-induced
arthritis. Clin Immunol. 122:75–84. 2007.
|
|
24
|
Fridenshtein A, Petrakova KV, Kuralesova
AI and Frolova GI: Precursor cells for osteogenic and hemopoietic
tissues. Analysis of heterotopic transplants of bone marrow.
Tsitologiia. 10:557–567. 1968.PubMed/NCBI
|
|
25
|
Lu L, Zhao C, Liu Y, et al: Therapeutic
benefit of TH-engineered mesenchymal stem cells for Parkinson’s
disease. Brain Res. 15:46–51. 2005.PubMed/NCBI
|
|
26
|
Studeny M, Marini FC, Dembinski JL, et al:
Mesenchymal stem cells: potential precursors for tumor stroma and
targeted-delivery vehicles for anticancer agents. J Natl Cancer
Inst. 96:1593–1603. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Friedenstein AJ, Deriglasova UF, Kulagina
NN, et al: Precursors for fibroblasts in different populations of
hematopoietic cells as detected by the in vitro colony assay
method. Exp Hematol. 2:83–92. 1974.PubMed/NCBI
|
|
28
|
Dressler MR, Butler DL and Boivin GP:
Effects of age on the repair ability of mesenchymal stem cells in
rabbit tendon. J Orthop Res. 23:287–293. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liu L, DiGirolamo CM, Navarro PA, Blasco
MA and Keefe DL: Telomerase deficiency impairs differentiation of
mesenchymal stem cells. Exp Cell Res. 294:1–8. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Stolzing A and Scutt A: Age-related
impairment of mesenchymal progenitor cell function. Aging Cell.
5:213–224. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zheng H, Martin JA, Duwayri Y, Falcon G
and Buckwalter JA: Impact of aging on rat bone marrow-derived stem
cell chondrogenesis. J Gerontol A Biol Sci Med Sci. 62:136–148.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Carrancio S, Lopez-Holgado N,
Sanchez-Guijo FM, et al: Optimization of mesenchymal stem cell
expansion procedures by cell separation and culture conditions
modification. Exp Hematol. 36:1014–1021. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zohar R, Sodek J and McCulloch CA:
Characterization of stromal progenitor cells enriched by flow
cytometry. Blood. 90:3471–3481. 1997.PubMed/NCBI
|
|
34
|
Matsubara T, Tsutsumi S, Pan H, et al: A
new technique to expand human mesenchymal stem cells using basement
membrane extracellular matrix. Biochem Biophys Res Commun.
313:503–508. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Schallmoser K, Rohde E, Reinisch A, et al:
Rapid large-scale expansion of functional mesenchymal stem cells
from unmanipulated bone marrow without animal serum. Tissue
engineering. 14:185–196. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hung SC, Yang DM, Chang CF, et al:
Immortalization without neoplastic transformation of human
mesenchymal stem cells by transduction with HPV16 E6/E7 genes. Int
J Cancer. 110:313–319. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Shi S, Gronthos S, Chen S, et al: Bone
formation by human postnatal bone marrow stromal stem cells is
enhanced by telomerase expression. Nat Biotechnol. 20:587–591.
2002. View Article : Google Scholar : PubMed/NCBI
|
